Ribonucleosides

Nucleosides in which the purine or pyrimidine base is combined with ribose. (Dorland, 28th ed)
DrugDrug NameDrug Indication
DB00118AdemetionineS-Adenosylmethionine (SAMe) is used as a drug in Europe for the treatment of depression, liver disorders, fibromyalgia, and osteoarthritis. It has also been introduced into the United States market as a dietary supplement for the support of bone and joint health, as well as mood and emotional well being.
DB00194VidarabineFor treatment of chickenpox - varicella, herpes zoster and herpes simplex
DB00242CladribineFor the treatment of active hairy cell leukemia (leukemic reticuloendotheliosis) as defined by clinically significant anemia, neutropenia, thrombocytopenia, or disease-related symptoms. Also used as an alternative agent for the treatment of chronic lymphocytic leukemia (CLL), low-grade non-Hodgkin's lymphoma, and cutaneous T-cell lymphoma.
DB00249IdoxuridineFor use in keratoconjunctivitis and keratitis caused by herpes simplex virus.
DB00322FloxuridineFor palliative management of gastrointestinal adenocarcinoma metastatic to the liver, when given by continuous regional intra-arterial infusion in carefully selected patients who are considered incurable by surgery or other means. Also for the palliative management of liver cancer (usually administered by hepatic intra-arterial infusion).
DB00441GemcitabineGemcitabine is indicated for the treatment of advanced ovarian cancer that has relapsed at least 6 months after completion of platinum-based therapy; metastatic ovarian cancer; inoperable, locally advanced (Stage IIIA or IIIB), or metastatic (Stage IV) non-small cell lung cancer; and locally advanced (nonresectable Stage II or Stage III) or metastatic (Stage IV) adenocarcinoma of the pancreas.
DB00552PentostatinFor the treatment of hairy cell leukaemia refractory to alpha interferon.
DB00640AdenosineUsed as an initial treatment for the termination of paroxysmal supraventricular tachycardia (PVST), including that associated with accessory bypass tracts, and is a drug of choice for terminating stable, narrow-complex supraventricular tachycardias (SVT). Also used as an adjunct to thallous chloride TI 201 myocardial perfusion scintigraphy (thallium stress test) in patients who are unable to exercise adequately, as well as an adjunct to vagal maneuvers and clinical assessment to establish a specific diagnosis of undefined, stable, narrow-complex SVT.
DB00709LamivudineFor the treatment of HIV infection and chronic hepatitis B (HBV).
DB00811RibavirinIndicated for the treatment of chronic Hepatitis C virus (HCV) infection in combination with other antiviral agents with the intent to cure or achieve a sustained virologic response (SVR). Typically added to improve SVR and reduce relapse rates [A19644]. The addition of ribavirin in Technivie therapy indicated for treating HCV genotype 1a and 4 infections is recommended in patients with or without cirrhosis. Resistance: viral genetic determinants resulting in variable response to ribavirin therapy has not been yet determined.
DB00879EmtricitabineIndicated, in combination with other antiretroviral agents, for the treatment of HIV-1 infection in adults and for postexposure prophylaxis of HIV infection in health care workers and others exposed occupationally or nonoccupationally via percutaneous injury or mucous membrane or nonintact skin contact with blood, tissues, or other body fluids associated with risk for transmission of the virus.
DB00900DidanosineFor use, in combination with other antiretroviral agents, in the treatment of HIV-1 infection in adults.
DB00928AzacitidineFor treatment of patients with the following French-American-British myelodysplastic syndrome subtypes: refractory anemia or refractory anemia with ringed sideroblasts (if accompanied by neutropenia or thrombocytopenia or requiring transfusions), refractory anemia with excess blasts, refractory anemia with excess blasts in transformation (now classified as acute myelogenous leukemia with multilineage dysplasia), and chronic myelomonocytic leukemia.
DB00943ZalcitabineFor the treatment of Human immunovirus (HIV) infections in conjunction with other antivirals.
DB00987CytarabineFor the treatment of acute non-lymphocytic leukemia, acute lymphocytic leukemia and blast phase of chronic myelocytic leukemia.
DB01073FludarabineFor the treatment of adult patients with B-cell chronic lymphocytic leukemia (CLL) who have not responded to or whose disease has progressed during treatment with at least one standard alkylating-agent containing regimen
DB01101CapecitabineFor the treatment of patients with metastatic breast cancer resistant to both paclitaxel and an anthracycline-containing chemotherapy regimen. May also be used in combination with docetaxel for the treatment of metastatic breast cancer in patients who have failed to respond to, or recurred or relasped during or following anthracycline-containing chemotherapy. Capecitabine is used alone as an adjuvant therapy following the complete resection of primary tumor in patients with stage III colon cancer when monotherapy with fluroprymidine is preferred. The use or capecitabine in combination regimens for advanced gastric cancer is currently being investigated.
DB01262DecitabineFor treatment of patients with myelodysplastic syndromes (MDS) including previously treated and untreated, de novo and secondary MDS of all French-American-British subtypes (refractory anemia, refractory anemia with ringed sideroblasts, refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, and chronic myelomonocytic leukemia) and intermediate-1, intermediate-2, and high-risk International Prognostic Scoring System groups (scores ≥0.5).
DB016295-fluorouridineNot Available
DB01910SinefunginNot Available
DB02097CytidineNot Available
DB02281FormycinNot Available
DB022825'-Deoxy-5'-MethylthioadenosineNot Available
DB023802'-DeoxyinosineNot Available
DB025028-Hydroxy-2'-DeoxyguanosineNot Available
DB02745UridineNot Available
DB027969-DeazainosineNot Available
DB02844S-Adenosyl-1,8-Diamino-3-ThiooctaneNot Available
DB02857GuanosineNot Available
DB02896MethylthioinosineNot Available
DB03068ZebularineNot Available
DB03172TubercidinNot Available
DB03326deoxycytidylyl-3',5'-guanosineNot Available
DB034937-MethylguanosineNot Available
DB036093-DeoxyguanosineNot Available
DB037165'-Fluoro-5'-DeoxyadenosineNot Available
DB04198Formycin BNot Available
DB04335InosineThe primary popular claim made for inosine, that it enhances exercise and athletic performance, is refuted by the available research data. There is some preliminary evidence that inosine may have some neurorestorative, anti-inflammatory, immunomodulatory and cardioprotective effects.
DB043853-DeazacytidineNot Available
DB044412-FluoroadenosineNot Available
DB046045-iodotubercidinNot Available
DB04627CyclouridineNot Available
DB04853BinodenosonFor cardiac pharmacologic stress SPECT imaging, which is used to diagnose coronary artery disease.
DB04860IsatoribineFor the treatment of Hepatitis C.
DB04954TecadenosonInvestigated for use/treatment in arrhythmia and atrial fibrillation.
DB04983DenufosolFor use as an inhaled treatment for cystic fibrosis.
DB05116ThymectacinInvestigated for use/treatment in colorectal cancer.
DB05494ElacytarabineInvestigated for use/treatment in leukemia (unspecified) and melanoma.
DB05511PiclidenosonInvestigated for use/treatment in cancer/tumors (unspecified), eye disorders/infections, psoriasis and psoriatic disorders, and rheumatoid arthritis. Can-Fite BioPharma has reported that by targeting the adenosine A3-receptor, CF101 may also be used to treat Crohn's disease, a serious gastrointestinal disorder.
DB06236ElvucitabineInvestigated for use/treatment in hepatitis (viral, B) and HIV infection.
DB06408TaribavirinInvestigated for use/treatment in hepatitis (viral, C).
DB06433TezacitabineInvestigated for use/treatment in colorectal cancer, lung cancer, leukemia (unspecified), and gastric cancer.
DB06656TAS-106Investigated for use/treatment in solid tumors and cancer/tumors (unspecified).
DB06683ClevudineInvestigated for use/treatment in hepatitis (viral, B).
DB08437PuromycinNot Available
DB08816TicagrelorTicagrelor is indicated for the prevention of thrombotic events like stroke or heart attack in patients with acute coronary syndrome or myocardial infarction with ST elevation.
DB08934SofosbuvirSofosbuvir is used in combination therapy with other antiviral medications to treat chronic hepatitis C virus (HCV) infected patients with HCV genoptypes 1-6, and to treat HCV and HIV co-infected patients. Depending on the level of cirrhosis or decompensation, combination therapy can also include either ribavirin alone or ribavirin and peg-interferon alfa. When used in combination with [DB09027] as the combination product Harvoni, sofosbuvir has the following indications: treatment of genotypes 1, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis; in combination with [DB00811] for genotype 1 infection with decompensated cirrhosis; or in combination with [DB00811] for the treatment of genotype 1 or 4 infection who are liver transplant recipients without cirrhosis or with compensated cirrhosis. When used in combination with [DB11613] as the combination product Epclusa, sofosbuvir is indicated for the treatment of adult patients with chronic hepatitis C virus (HCV) genotypes 1, 2, 3, 4, 5, or 6 infection without cirrhosis or with compensated cirrhosis, or in combination with [DB00811] if associated with decompensated cirrhosis. Resistance: Reduced susceptibility to sofosbuvir has been associated with the NS5B substitution mutation S282T [A19634].
DB09144Uridine triacetateMarketed as the product Xuriden (FDA), uridine triacetate is indicated for the treatment of hereditary orotic aciduria. Marketed as the product Vistogard (FDA), uridine triacetate is indicated for the emergency treatment of adult and pediatric patients in the following situations: following a fluorouracil or capecitabine overdose regardless of the presence of symptoms; or who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration.
DB116672'-cyano-2'-deoxy-1-(beta-D-arabinofuranosyl)cytosineNot Available
DB11918GuadecitabineNot Available
DB11998SorivudineNot Available
DB12028BroxuridineNot Available
DB12045MericitabineNot Available
DB12156CordycepinNot Available
DB12443SonedenosonNot Available
DB12470DexelvucitabineNot Available
DB12484TetrahydrouridineNot Available
DB12564Gemcitabine elaidateNot Available
DB12606NetivudineNot Available
DB12691UK-432097Not Available
DB12753RacivirNot Available
DB12855ApricitabineNot Available
DB12901FiacitabineNot Available
DB12906LY-2334737Not Available
DB12947DoxifluridineNot Available
DB129575-fluoro-2'-deoxycytidineNot Available
DB130302'-fluoro-5-ethylarabinosyluracilNot Available
DB13156Inosine pranobexInosine pranobex is also indicated for mucocutaneous infections due to herpes simplex virus (type 1 and type II) and for treatment of genital warts as adjunctive therapy to podophyllin or carbon dioxide laser.
DB13243TiazofurineNot Available
DB13421EdoxudineEdoxudine was used in Europe, in the form of a topical antiviral, for the treatment of human herpes keratitis.[A32643] Human herpes keratitis is an inflammation of the cornea in the eye caused by herpes simplex virus infection. This infection is a cause of significant morbidity whose incidence is significantly increased in the presence of recurrent infection and it can even produce corneal blindness.[A32645] Edoxudine 3% cream was also indicated for the treatment of dermal herpes simplex virus.[A32643] This virus can produce an infection ubiquitously and it is highly contagious. There are two types of herpes virus, type 1 that is mainly transmitted by oral-to-oral contact and type 2 that is sexually transmitted.[L2411]
DB13916ToyocamycinNot Available
DB139212'-C-methylcytidineNot Available
DB13122TrabodenosonNot Available
DB01752S-adenosyl-L-homocysteineNot Available
DB03312BrivudineNot Available
DrugDrug NameTargetType
DB00118AdemetionineGlycine N-methyltransferasetarget
DB00118AdemetionineS-adenosylmethionine decarboxylase proenzymetarget
DB00118AdemetionineS-adenosylmethionine synthase isoform type-2target
DB00118AdemetionineCystathionine beta-synthasetarget
DB00118AdemetionineS-adenosylmethionine synthase isoform type-1target
DB00118AdemetionineCytochrome P450 2E1enzyme
DB00118AdemetionineCatechol O-methyltransferasetarget
DB00118AdemetionineSpermidine synthaseenzyme
DB00118AdemetionineCap-specific mRNA (nucleoside-2'-O-)-methyltransferase 1target
DB00118AdemetionineArsenite methyltransferasetarget
DB00194VidarabineDNAtarget
DB00194VidarabineDNA polymerase catalytic subunittarget
DB00194VidarabineThymidine kinasetarget
DB00194VidarabineThymidine kinasetarget
DB00194VidarabineAdenosine deaminaseenzyme
DB00242CladribinePurine nucleoside phosphorylasetarget
DB00242CladribineDNAtarget
DB00242CladribineDeoxycytidine kinaseenzyme
DB00242CladribineRibonucleoside-diphosphate reductase large subunittarget
DB00242CladribineRibonucleoside-diphosphate reductase subunit M2target
DB00242CladribineRibonucleoside-diphosphate reductase subunit M2 Btarget
DB00242CladribineDNA polymerase alpha catalytic subunittarget
DB00242CladribineDNA polymerase epsilon catalytic subunit Atarget
DB00242CladribineDNA polymerase epsilon subunit 2target
DB00242CladribineDNA polymerase epsilon subunit 3target
DB00242CladribineDNA polymerase epsilon subunit 4target
DB00242CladribineATP-binding cassette sub-family G member 2transporter
DB00242CladribineSolute carrier family 28 member 3transporter
DB00249IdoxuridineThymidine kinasetarget
DB00249IdoxuridineDNAtarget
DB00322FloxuridineThymidylate synthasetarget
DB00322FloxuridineThymidine phosphorylaseenzyme
DB00322FloxuridineCytochrome P450 2C9enzyme
DB00322FloxuridineThyroxine-binding globulincarrier
DB00441GemcitabineRibonucleoside-diphosphate reductase large subunittarget
DB00441GemcitabineUMP-CMP kinasetarget
DB00441GemcitabineThymidylate synthasetarget
DB00441GemcitabineCytidine deaminaseenzyme
DB00441GemcitabineDeoxycytidine kinaseenzyme
DB00441GemcitabineMultidrug resistance protein 1transporter
DB00441GemcitabineMultidrug resistance-associated protein 7transporter
DB00441GemcitabineEquilibrative nucleoside transporter 1transporter
DB00441GemcitabineDNAtarget
DB00441GemcitabineSodium/nucleoside cotransporter 1transporter
DB00441GemcitabineEquilibrative nucleoside transporter 2transporter
DB00441GemcitabineSolute carrier family 28 member 3transporter
DB00552PentostatinAdenosine deaminasetarget
DB00640AdenosineAdenosine receptor A3target
DB00640AdenosineAdenosine deaminaseenzyme
DB00640AdenosineAdenosine kinaseenzyme
DB00640AdenosineAdenosine receptor A1target
DB00640AdenosineAdenosine receptor A2atarget
DB00640AdenosineAdenosine receptor A2btarget
DB00640AdenosineSolute carrier family 28 member 3transporter
DB00709LamivudineDNAtarget
DB00709LamivudineProtein Ptarget
DB00709LamivudineMultidrug resistance-associated protein 1transporter
DB00709LamivudineSolute carrier family 22 member 6transporter
DB00709LamivudineATP-binding cassette sub-family G member 2transporter
DB00709LamivudineReverse transcriptase/RNaseHtarget
DB00709LamivudineSolute carrier family 22 member 1transporter
DB00709LamivudineSolute carrier family 22 member 2transporter
DB00709LamivudineSolute carrier family 22 member 3transporter
DB00709LamivudineDeoxycytidine kinaseenzyme
DB00709LamivudineUMP-CMP kinaseenzyme
DB00709LamivudinePhosphoglycerate kinase 1enzyme
DB00709LamivudineNucleoside diphosphate kinase Aenzyme
DB00709LamivudineNucleoside diphosphate kinase Benzyme
DB00709LamivudineCholine-phosphate cytidylyltransferase Aenzyme
DB00709LamivudineEthanolamine-phosphate cytidylyltransferaseenzyme
DB00709LamivudineMultidrug resistance protein 1transporter
DB00709LamivudineMultidrug resistance-associated protein 4transporter
DB00709LamivudineCanalicular multispecific organic anion transporter 2transporter
DB00709LamivudineCanalicular multispecific organic anion transporter 1transporter
DB00709Lamivudine5'(3')-deoxyribonucleotidase, cytosolic typeenzyme
DB00709LamivudineSerum albumincarrier
DB00811RibavirinRNA-directed RNA polymerase Ltarget
DB00811RibavirinEctonucleotide pyrophosphatase/phosphodiesterase family member 1target
DB00811RibavirinRNA-directed RNA polymerase catalytic subunittarget
DB00811RibavirinCytosolic purine 5'-nucleotidasetarget
DB00811RibavirinInosine-5'-monophosphate dehydrogenase 1target
DB00811RibavirinGenome polyproteintarget
DB00811RibavirinInosine-5'-monophosphate dehydrogenase 2target
DB00811RibavirinAdenosine kinaseenzyme
DB00811RibavirinEquilibrative nucleoside transporter 1transporter
DB00811RibavirinSolute carrier family 28 member 3transporter
DB00879EmtricitabineReverse transcriptase/RNaseHtarget
DB00879EmtricitabineDeoxycytidine kinaseenzyme
DB00879EmtricitabineSerum albumincarrier
DB00900DidanosineSolute carrier family 22 member 6transporter
DB00900DidanosinePurine nucleoside phosphorylasetarget
DB00900DidanosineReverse transcriptase/RNaseHtarget
DB00900DidanosineEquilibrative nucleoside transporter 1transporter
DB00900DidanosineEquilibrative nucleoside transporter 2transporter
DB00900DidanosineSerum albumincarrier
DB00928AzacitidineDNA (cytosine-5)-methyltransferase 1target
DB00928AzacitidineCytidine deaminaseenzyme
DB00928AzacitidineDNAtarget
DB00928AzacitidineRNAtarget
DB00943ZalcitabineDeoxycytidine kinaseenzyme
DB00943ZalcitabineSolute carrier family 22 member 6transporter
DB00943ZalcitabineSolute carrier family 22 member 7transporter
DB00943ZalcitabineReverse transcriptase/RNaseHtarget
DB00943ZalcitabineEquilibrative nucleoside transporter 1transporter
DB00943ZalcitabineEquilibrative nucleoside transporter 2transporter
DB00943ZalcitabineSerum albumincarrier
DB00987CytarabineDNA polymerase betatarget
DB00987CytarabineCytidine deaminaseenzyme
DB00987CytarabineSolute carrier family 22 member 1transporter
DB00987CytarabineMultidrug resistance-associated protein 7transporter
DB00987CytarabineEquilibrative nucleoside transporter 1transporter
DB00987CytarabineDNAtarget
DB00987CytarabineCytochrome P450 3A4enzyme
DB00987CytarabineDeoxycytidine kinaseenzyme
DB00987Cytarabine5'-nucleotidaseenzyme
DB00987CytarabineDeoxycytidylate deaminaseenzyme
DB01073FludarabineDNA polymerase alpha catalytic subunittarget
DB01073FludarabineRibonucleoside-diphosphate reductase large subunittarget
DB01073FludarabineEquilibrative nucleoside transporter 1transporter
DB01073FludarabineDNAtarget
DB01073FludarabineDeoxycytidine kinasetarget
DB01073FludarabineSolute carrier family 28 member 3transporter
DB01101CapecitabineThymidylate synthasetarget
DB01101CapecitabineThymidine phosphorylaseenzyme
DB01101CapecitabineCytidine deaminaseenzyme
DB01101CapecitabineLiver carboxylesterase 1enzyme
DB01101CapecitabineDihydropyrimidine dehydrogenase [NADP(+)]enzyme
DB01101CapecitabineCytochrome P450 2C9enzyme
DB01101CapecitabineDNAtarget
DB01101CapecitabineRNAtarget
DB01262DecitabineDNAtarget
DB01262DecitabineDNA (cytosine-5)-methyltransferase 1target
DB01262DecitabineDeoxycytidine kinaseenzyme
DB016295-fluorouridineUridine phosphorylasetarget
DB016295-fluorouridineSuperoxide dismutase [Cu-Zn]target
DB016295-fluorouridineThyroxine-binding globulincarrier
DB01910SinefunginModification methylase RsrItarget
DB01910SinefunginRdmBtarget
DB01910SinefunginrRNA adenine N-6-methyltransferasetarget
DB01910SinefunginModification methylase TaqItarget
DB02097CytidineUridine-cytidine kinase 2target
DB02281FormycinS-methyl-5'-thioadenosine phosphorylasetarget
DB02281Formycin5'-methylthioadenosine/S-adenosylhomocysteine nucleosidasetarget
DB022825'-Deoxy-5'-MethylthioadenosineModification methylase RsrItarget
DB022825'-Deoxy-5'-MethylthioadenosineS-methyl-5'-thioadenosine phosphorylasetarget
DB02745UridineU6 snRNA-associated Sm-like protein LSm6target
DB02745UridineNucleoside-specific channel-forming protein tsxtarget
DB02745UridineEquilibrative nucleoside transporter 1transporter
DB027969-DeazainosinePurine nucleoside phosphorylasetarget
DB02844S-Adenosyl-1,8-Diamino-3-ThiooctaneSpermidine synthasetarget
DB02857GuanosineDNA polymerasetarget
DB02857GuanosinePurine nucleoside phosphorylasetarget
DB02857GuanosinePurine nucleoside phosphorylasetarget
DB02896MethylthioinosinePurine nucleoside phosphorylase DeoD-typetarget
DB03068ZebularineCytidine deaminasetarget
DB03172TubercidinPurine nucleoside phosphorylase DeoD-typetarget
DB03326deoxycytidylyl-3',5'-guanosineRibonuclease pancreatictarget
DB034937-MethylguanosineCap-specific mRNA (nucleoside-2'-O-)-methyltransferasetarget
DB036093-DeoxyguanosinePurine nucleoside phosphorylasetarget
DB037165'-Fluoro-5'-Deoxyadenosine5'-fluoro-5'-deoxy-adenosine synthasetarget
DB04198Formycin BPurine nucleoside phosphorylase DeoD-typetarget
DB04198Formycin BHypoxanthine-guanine phosphoribosyltransferasetarget
DB04335InosinePurine nucleoside phosphorylasetarget
DB04335InosineIAG-nucleoside hydrolasetarget
DB04335InosinePurine nucleoside phosphorylase DeoD-typetarget
DB04335InosineXanthine dehydrogenase/oxidaseenzyme
DB04335InosineSolute carrier family 28 member 3transporter
DB043853-DeazacytidineCytidine deaminasetarget
DB044412-FluoroadenosinePurine nucleoside phosphorylase DeoD-typetarget
DB046045-iodotubercidinCasein kinase I isoform gamma-2target
DB046045-iodotubercidinSerine/threonine-protein kinase haspintarget
DB046045-iodotubercidinMitogen-activated protein kinase 3target
DB04627CyclouridineUridine phosphorylasetarget
DB04853BinodenosonAdenosine receptor A2atarget
DB04860IsatoribineToll-like receptor 7target
DB04954TecadenosonAdenosine receptor A1target
DB04983DenufosolP2Y purinoceptor 2target
DB05116ThymectacinThymidylate synthasetarget
DB05494ElacytarabineDeoxycytidine kinasetarget
DB05511PiclidenosonAdenosine receptor A3target
DB06408TaribavirinDNAtarget
DB06408TaribavirinRNA-directed RNA polymerase Ltarget
DB06408TaribavirinEctonucleotide pyrophosphatase/phosphodiesterase family member 1target
DB06408TaribavirinRNA-directed RNA polymerase catalytic subunittarget
DB06408TaribavirinCytosolic purine 5'-nucleotidasetarget
DB06408TaribavirinInosine-5'-monophosphate dehydrogenase 1target
DB06433TezacitabineRibonucleoside-diphosphate reductase large subunittarget
DB06433TezacitabineThymidine phosphorylaseenzyme
DB08437Puromycin60S ribosomal protein L10-liketarget
DB08437Puromycin60S ribosomal protein L13atarget
DB08437Puromycin60S ribosomal protein L23target
DB08437Puromycin60S ribosomal protein L15target
DB08437Puromycin60S ribosomal protein L19target
DB08437Puromycin60S ribosomal protein L23atarget
DB08437PuromycinProbable ribosome biogenesis protein RLP24target
DB08437Puromycin60S ribosomal protein L26-like 1target
DB08437Puromycin60S ribosomal protein L8target
DB08437Puromycin60S ribosomal protein L37target
DB08437Puromycin60S ribosomal protein L3target
DB08437Puromycin60S ribosomal protein L11target
DB08437PuromycinLeucyl/phenylalanyl-tRNA--protein transferasetarget
DB08816TicagrelorCytochrome P450 3A4enzyme
DB08816TicagrelorP2Y purinoceptor 12target
DB08816TicagrelorMultidrug resistance protein 1transporter
DB08816TicagrelorCytochrome P450 2D6enzyme
DB08816TicagrelorCytochrome P450 2C9enzyme
DB08934SofosbuvirMultidrug resistance protein 1transporter
DB08934SofosbuvirATP-binding cassette sub-family G member 2transporter
DB08934SofosbuvirRNA-dependent RNA-polymerasetarget
DB08934SofosbuvirLysosomal protective proteinenzyme
DB08934SofosbuvirCarboxylesteraseenzyme
DB08934SofosbuvirHistidine triad nucleotide-binding protein 1enzyme
DB08934SofosbuvirUMP-CMP kinaseenzyme
DB08934SofosbuvirNucleoside diphosphate kinase Aenzyme
DB12855ApricitabineReverse transcriptase/RNaseHtarget
DB13421EdoxudineSerum albumincarrier
DB13421EdoxudineDNA polymerasetarget
DB01752S-adenosyl-L-homocysteineCap-specific mRNA (nucleoside-2'-O-)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineCobalt-precorrin-4 C(11)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineProtein-L-isoaspartate(D-aspartate) O-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineGenome polyproteintarget
DB01752S-adenosyl-L-homocysteinePhenylethanolamine N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineCyclopropane mycolic acid synthase 2target
DB01752S-adenosyl-L-homocysteineModification methylase RsrItarget
DB01752S-adenosyl-L-homocysteineCatechol O-methyltransferase domain-containing protein 1target
DB01752S-adenosyl-L-homocysteineCarminomycin 4-O-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineGuanidinoacetate N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineRelease factor glutamine methyltransferasetarget
DB01752S-adenosyl-L-homocysteineRelease factor glutamine methyltransferasetarget
DB01752S-adenosyl-L-homocysteineProtein arginine N-methyltransferase 3target
DB01752S-adenosyl-L-homocysteineHistamine N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineRibosomal RNA small subunit methyltransferase Htarget
DB01752S-adenosyl-L-homocysteinerRNA adenine N-6-methyltransferasetarget
DB01752S-adenosyl-L-homocysteinetRNA (cytosine(38)-C(5))-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineGlycine N-methyltransferasetarget
DB01752S-adenosyl-L-homocysteinetRNA (cytidine(34)-2'-O)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineModification methylase PvuIItarget
DB01752S-adenosyl-L-homocysteineDNA adenine methylasetarget
DB01752S-adenosyl-L-homocysteineCyclopropane mycolic acid synthase 3target
DB01752S-adenosyl-L-homocysteineProtein arginine N-methyltransferase 1target
DB01752S-adenosyl-L-homocysteineSiroheme synthasetarget
DB01752S-adenosyl-L-homocysteineModification methylase HhaItarget
DB01752S-adenosyl-L-homocysteineHistone-lysine N-methyltransferase SETD7target
DB01752S-adenosyl-L-homocysteinetRNA (guanine-N(1)-)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineCyclopropane mycolic acid synthase MmaA2target
DB01752S-adenosyl-L-homocysteineDiphthine synthasetarget
DB01752S-adenosyl-L-homocysteineRdmBtarget
DB01752S-adenosyl-L-homocysteinetRNA (guanine-N(1)-)-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineUroporphyrinogen-III C-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineUncharacterized proteintarget
DB01752S-adenosyl-L-homocysteineChemotaxis protein methyltransferasetarget
DB01752S-adenosyl-L-homocysteineModification methylase TaqItarget
DB01752S-adenosyl-L-homocysteineProtein-L-isoaspartate O-methyltransferasetarget
DB01752S-adenosyl-L-homocysteineHistamine N-methyltransferaseenzyme
DB03312BrivudineThymidine kinasetarget